Finance

Beta
Lists
354200:KOSDAQ
NGeneBio Co Ltd
₩949.00
+3.04%
(+28.00) 1D
Jun 9, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 354200...
Open
₩922
High
₩985
Low
₩922
Mkt. cap
25.44B
Avg. vol.
672.82K
Volume
42.51K
52-wk high
₩2,765
52-wk low
₩906
EPS
-₩167
Shares outstanding
26.81M
No. of employees
56
Open
₩922
High
₩985
Low
₩922
Mkt. cap
25.44B
Avg. vol.
672.82K
Volume
42.51K
52-wk high
₩2,765
52-wk low
₩906
EPS
-₩167
Shares outstanding
26.81M
No. of employees
56
News stories
From sources across the web
About NGeneBio Co Ltd
CEO-
Employees56
Founded2015
Headquarters-
SectorBiotechnology
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.85B
5.43B
11.97B
11.95B
Cost of goods sold
1.51B
4.40B
10.51B
10.54B
Cost of revenue
1.51B
4.40B
10.51B
10.54B
Research and development expenses
470.99M
339.50M
358.78M
328.91M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.19B
1.96B
2.57B
2.38B
Operating expense
3.02B
2.68B
3.36B
2.97B
Total operating expenses
4.53B
7.08B
13.88B
13.52B
Operating income
-2.68B
-1.65B
-1.90B
-1.57B
Other non operating income
-779.28M
-21.71M
351.37M
-1.84B
EBT including unusual items
-3.94B
-1.90B
3.70B
-4.18B
EBT excluding unusual items
-3.80B
-1.86B
-2.43B
-4.04B
Income tax expense
-
-
-965.45M
-
Effective tax rate
-
-
-26.10%
-
Other operating expenses
165.70M
61.39M
89.96M
53.98M
Net income
-5.39B
-1.90B
4.48B
-4.19B
Net profit margin
-291.69%
-34.92%
37.41%
-35.07%
Earnings per share
-
-
-
-
Interest and investment income
36.21M
-2.06M
33.33M
21.11M
Interest expense
-194.14M
-274.25M
-974.81M
-1.17B
Net interest expenses
-157.93M
-276.31M
-941.48M
-1.15B
Depreciation and amortization charges
135.86M
116.08M
118.65M
132.82M
EBITDA
-2.06B
-1.27B
-1.51B
-1.21B
Gain or loss from assets sale
1.91B
13.89M
27.34M
-311.57M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more